NextPlat Q3 2024 net loss $4.2M vs prior-year income; 9-month revenue $49.8M (+136%)

NextPlat Corp

2024-Q3 EPS reported -$0.58 revenue$49,849,000

Net loss attributable to common shareholders $4.2M ($0.22/sh) in Q3 2024 vs net income $3.4M ($0.17/sh) in Q3 2023.
Nine-month consolidated revenue $49.8M, up 136% YoY, driven by Progressive Care acquisition. Full-year guidance $60–65M.
Non-cash impairment losses of $13.7M recognized in 9M 2024 on Progressive Care goodwill; company expects no further impairments.
Healthcare Operations filled 128,000 prescriptions in Q3 (+5% YoY); e-commerce airtime revenue grew 94% vs prior year.
Completed all-stock merger with Progressive Care on Oct 1; OPKO China e-commerce program extended four years, expanded to Japan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.